MPCCC Cancer Research Resource (CRR) Grant: Applications now open!

The MPCCC’s Cancer Research Resource (CRR) Grant Opportunity is now open to cancer researchers across the consortium. Each MPCCC CRR Grant will be valued between $50,000-$200,000, with a maximum of two approved in 2024. Apply before Friday, 17 May 2024.

MPCCC Precision Treatment Accelerator Grant Recipients Announced

Monash Partners Comprehensive Cancer Consortium (MPCCC) is thrilled to announce the successful applicants of the Precision Treatment Accelerator Grant. A total of $426,184 has been awarded to four innovative projects, each poised to drive significant progress in precision cancer treatment

Winners of the 2023 MPCCC Outstanding Researcher Award

Congratulations to Dr Claire Sun and Dr Lisa Mielke who have won the prestigious 2023 MPCCC Outstanding Researcher Award. The award aims to recognise and celebrate the achievements of Victoria’s best and brightest mid-career cancer researchers.

Bridging the Gap in Cancer Care

As we approach World Cancer Day, the MPCCC's Precision Cancer Program is a testament to the transformative power of targeted interventions in closing health care gaps. We can pave the way for a future where access to cutting-edge cancer care is not determined by one's postal code, but by the fundamental right in this country to healthcare for all.

Tim Richardson visits MPCCC

The MPCCC was delighted to host a visit from the Victorian Parliamentary Secretary for Mental Health & Suicide Prevention and Health Infrastructure, Mr Tim Richardson MP

Celebrating Excellence in Prostate Cancer Research: A/Prof Wee Loon Ong Wins MPCCC prize for best abstract in cancer research

Australian first program supports Victorian cancer patients’ access to precision medicine

MPCCC becomes member site in OMICO national clinical trial network (ONCTN)

MPCCC and Omico have signed an MOU that saw MPCCC become a member site in Omico national clinical trial network (ONCTN)

MPCCC hosts 200 cancer experts

More than 200 experts in cancer genomics gathered in Melbourne last week to discuss how we can improve access to precision oncology for patients.

World-first research discovers ‘Dr Jekyll and Mr Hyde’ cancer cells

Melbourne researchers have discovered how a rogue protein produces ‘Dr Jekyll and Mr Hyde’ cancer cells, which could lead to improved treatments for melanoma and other cancers.

What these leading oncologists and researchers want you to know this IWD

Women are still facing barriers accessing certain cancer treatments and testing in some parts of Victoria

MPCCC on the move: Roadshows Deepen Collaboration

The Monash Partners Comprehensive Cancer Consortium (MPCCC) has embarked on a roadshow series to continue to improve connectivity and collaboration with our partner hospitals.

Capturing the essence of change: Unveiling the Artistry of Graphic Recordings at the Precision Oncology Summit 2023

Artist draws conference as it happens!